Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11937927 Transcutaneous analyte sensor

Patent 11937927 was granted and assigned to Dexcom on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert J. Boock0

Sebastian Bohm0

Paul V. Neale0

James H. Brauker0

Peter C. Simpson0

Date of Patent

March 26, 2024

0

Patent Application Number

168571070

Date Filed

April 23, 2020

0

Patent Citations

US Patent 7029444 Real time self-adjusting calibration algorithm

0

US Patent 7033322 Implantable sensor

0

US Patent 7041057 Tissue interface device

0

US Patent 7060059 System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device

0

US Patent 7066884 System, method, and device for non-invasive body fluid sampling and analysis

0

US Patent 6892085 Glucose sensor package system

0

US Patent 6895265 Implantable sensor

0

US Patent 6936006 Atraumatic insertion of a subcutaneous device

0

...

Patent Primary Examiner

Navin Natnithithadha

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

A transcutaneous sensor device configured for continuously measuring analyte concentrations in a host is provided. In some embodiments, the transcutaneous sensor device

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11937927 Transcutaneous analyte sensor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool